Researchers developed a novel drug delivery system for polydopamine (PDA)-CV@PD-1 inhibitors, combining the protective and adhesive properties of PDA with the biocompatibility and drug-loading capacity of Chlorella vulgaris microalgae.
[Advanced Science]